enGene Holdings is trading at $1.52, up 5.17% on November 3, 2026; biotech-sector strength is the clearest available context, but is not confirmed as the cause.
- The provided market context reports biotech ETF XBI up 2.13% during regular trading.
- No company-specific announcement dated November 3 has been identified; the latest listed company releases predate the session.